E
Eliane Gluckman
Researcher at University of Paris
Publications - 694
Citations - 48573
Eliane Gluckman is an academic researcher from University of Paris. The author has contributed to research in topics: Transplantation & Bone marrow. The author has an hindex of 112, co-authored 679 publications receiving 46415 citations. Previous affiliations of Eliane Gluckman include Medical College of Wisconsin & Leiden University.
Papers
More filters
Journal ArticleDOI
Palivizumab Treatment of Respiratory Syncytial Virus Infection after Allogeneic Hematopoietic Stem Cell Transplantation
Flore Sicre de Fontbrune,Marie Robin,Raphaël Porcher,Catherine Scieux,Régis Peffault de Latour,Christèle Ferry,Vanderson Rocha,Karim Boudjedir,Agnès Devergie,Anne Bergeron,Eliane Gluckman,Elie Azoulay,Jordane Lapalu,Gérard Socié,Patricia Ribaud +14 more
TL;DR: Among 40 allogeneic stem cell transplant recipients who developed symptomatic respiratory syncytial virus infection, including 22 patients with lower respiratory tract infection, 19 received palivizumab and did not prevent progression to lower respiratory infection and had no impact on the overall survival rate.
Journal ArticleDOI
Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia.
Renata Bizzetto,Carmen Bonfim,Vanderson Rocha,Gérard Socié,Franco Locatelli,Kawah Chan,Oscar Ramirez,Joel Stein,Samir Kanaan Nabhan,Eliana C M Miranda,Jakob Passweg,Carmino Antonio De Souza,Eliane Gluckman +12 more
TL;DR: In patients with hereditary bone marrow failure syndromes, related umbilical cord blood transplantation is associated with excellent outcomes while increasing cell dose and better HLA matching might provide better results in unrelated umbilicals cord blood transplants.
Journal ArticleDOI
Does cord blood transplantation result in lower graft-versus-host disease? It takes more than two to tango.
Journal Article
Treatment with marrow transplantation or immunosuppression of childhood acquired severe aplastic anemia: a report from the EBMT SAA Working Party.
Anna Locasciulli,L. Van 't Veer,Almalina Bacigalupo,Jill Hows,M. T. Van Lint,Eliane Gluckman,Catherine Nissen,Shaun R. McCann,Jaak M. Vossen,A. Schrezenmeier,Wolfgang Hinterberger,A. Marin +11 more
TL;DR: The results suggest that IS is a satisfactory alternative therapy for children with moderately SAA in the absence of an HLA-identical sibling, although BMT remains the treatment of choice.
Journal ArticleDOI
Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplantation
Raja Brauner,L. Adan,Jean-Claude Souberbielle,H. Esperou,J. Michon,A Devergie,Eliane Gluckman,Jean-Michel Zucker +7 more
TL;DR: The individual height changes between BMT and the last clinical evaluation before GH therapy were not correlated with the age at BMT, GH peak after stimulation, plasma IGF-I concentration, or IGFBP-3 concentration, which suggest that bone irradiation induces lesions causing resistance to IGF-i.